193 related articles for article (PubMed ID: 35435976)
1. Protective Effect of Intestinal Blautia Against Neutropenic Fever in Allogeneic Transplant Recipients.
Rashidi A; Peled JU; Ebadi M; Rehman TU; Elhusseini H; Marcello LT; Halaweish H; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Clin Infect Dis; 2022 Nov; 75(11):1912-1920. PubMed ID: 35435976
[TBL] [Abstract][Full Text] [Related]
2. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
van Lier YF; Vos J; Blom B; Hazenberg MD
Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
[TBL] [Abstract][Full Text] [Related]
4. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
[TBL] [Abstract][Full Text] [Related]
5. Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
Weber D; Hiergeist A; Weber M; Ghimire S; Salzberger B; Wolff D; Poeck H; Gessner A; Edinger M; Herr W; Meedt E; Holler E
Clin Infect Dis; 2023 Nov; 77(10):1432-1439. PubMed ID: 37386935
[TBL] [Abstract][Full Text] [Related]
6. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
[TBL] [Abstract][Full Text] [Related]
7. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.
Ilett EE; Jørgensen M; Noguera-Julian M; Nørgaard JC; Daugaard G; Helleberg M; Paredes R; Murray DD; Lundgren J; MacPherson C; Reekie J; Sengeløv H
Blood Adv; 2020 Nov; 4(22):5797-5809. PubMed ID: 33232475
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease.
Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Kim CS; Shin DM; Min CK
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1933-1943. PubMed ID: 31195137
[TBL] [Abstract][Full Text] [Related]
10. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
[TBL] [Abstract][Full Text] [Related]
11. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Han L; Zhang H; Chen S; Zhou L; Li Y; Zhao K; Huang F; Fan Z; Xuan L; Zhang X; Dai M; Lin Q; Jiang Z; Peng J; Jin H; Liu Q
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1944-1955. PubMed ID: 31299215
[TBL] [Abstract][Full Text] [Related]
13. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
Ramalingam S; Siamakpour-Reihani S; Bohannan L; Ren Y; Sibley A; Sheng J; Ma L; Nixon AB; Lyu J; Parker DC; Bain J; Muehlbauer M; Ilkayeva O; Kraus VB; Huebner JL; Spitzer T; Brown J; Peled JU; van den Brink M; Gomes A; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Sung AD
PLoS One; 2021; 16(6):e0252995. PubMed ID: 34170918
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
Masetti R; Leardini D; Muratore E; Fabbrini M; D'Amico F; Zama D; Baccelli F; Gottardi F; Belotti T; Ussowicz M; Fraczkiewicz J; Cesaro S; Zecca M; Merli P; Candela M; Pession A; Locatelli F; Prete A; Brigidi P; Turroni S
Blood; 2023 Oct; 142(16):1387-1398. PubMed ID: 37856089
[TBL] [Abstract][Full Text] [Related]
16. Loss of microbiota-derived protective metabolites after neutropenic fever.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Halaweish H; Holtan SG; Ramamoorthy S; Weisdorf DJ; Khoruts A; Staley C
Sci Rep; 2022 Apr; 12(1):6244. PubMed ID: 35428797
[TBL] [Abstract][Full Text] [Related]
17. Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Nalluri H; Kaiser T; Ramamoorthy S; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Blood Adv; 2021 Oct; 5(20):3937-3950. PubMed ID: 34478486
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
Bansal R; Park H; Taborda CC; Gordillo C; Mapara MY; Assal A; Uhlemann AC; Reshef R
Transplant Cell Ther; 2022 Mar; 28(3):135-144. PubMed ID: 34958974
[TBL] [Abstract][Full Text] [Related]
19. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
Front Immunol; 2021; 12():720354. PubMed ID: 34539656
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients.
Konuma T; Kohara C; Watanabe E; Takahashi S; Ozawa G; Suzuki K; Mizukami M; Nagai E; Jimbo K; Kaito Y; Isobe M; Kato S; Takahashi S; Chiba A; Miyake S; Tojo A
J Immunol; 2020 Mar; 204(6):1462-1473. PubMed ID: 32041784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]